These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 9385404)

  • 1. Potency testing of inactivated tissue culture vaccine against Japanese encephalitis using antigen capture ELISA.
    Joshi AM; Walimbe AM; Banerjee K
    Acta Virol; 1997 Jun; 41(3):157-9. PubMed ID: 9385404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibody-based antigen capture immunoassay for detection of circulating non-structural protein NS1: implications for early diagnosis of Japanese encephalitis virus infection.
    Kumar JS; Parida M; Rao PV
    J Med Virol; 2011 Jun; 83(6):1063-70. PubMed ID: 21503922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of cytoxan on immune response of Japanese encephalitis virus killed and live vaccines].
    Fang QA; Chen BQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Oct; 11(5):317-21. PubMed ID: 2561510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and evaluation of an enzyme-linked immunosorbent assay for quantifying antibodies to Japanese encephalitis virus nonstructural 1 protein to detect subclinical infections in vaccinated horses.
    Konishi E; Shoda M; Ajiro N; Kondo T
    J Clin Microbiol; 2004 Nov; 42(11):5087-93. PubMed ID: 15528700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A test production of inactivated mouse brain JE vaccine in Thailand.
    Pongpairoj S; Choakouychai B; Boonrueng C; Kutirakan P; Ahandrik S; Leelasiri K; Phanthumachinda B
    Southeast Asian J Trop Med Public Health; 1989 Dec; 20(4):647-52. PubMed ID: 2561721
    [No Abstract]   [Full Text] [Related]  

  • 7. Japanese encephalitis DNA vaccine candidates expressing premembrane and envelope genes induce virus-specific memory B cells and long-lasting antibodies in swine.
    Konishi E; Yamaoka M; Kurane I; Mason PW
    Virology; 2000 Mar; 268(1):49-55. PubMed ID: 10683326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of protection by Japanese encephalitis (JE) vaccine against a Japanese strain and an Indian strain of JE virus.
    Das BC; Chakrabarti SK; Sarkar JK; Mukherjee KK
    Indian J Pathol Microbiol; 1976 Oct; 19(4):239-43. PubMed ID: 191395
    [No Abstract]   [Full Text] [Related]  

  • 9. Japanese encephalitis vaccines: moving away from the mouse brain.
    Zanin MP; Webster DE; Martin JL; Wesselingh SL
    Expert Rev Vaccines; 2003 Jun; 2(3):407-16. PubMed ID: 12903806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
    Yang SE; Pan MJ; Tseng HF; Liau MY
    Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines--report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies.
    Ferguson M; Johnes S; Li L; Heath A; Barrett A
    Biologicals; 2008 Mar; 36(2):111-6. PubMed ID: 17892945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of murine bone marrow-derived dendritic cells loaded with inactivated virus as a vaccine against Japanese encephalitis virus.
    Li Y; Xu M; Chen L; Zhu J; Ye J; Liu X; Sun Y; Chen H; Cao S
    Vaccine; 2009 Oct; 27(43):6004-10. PubMed ID: 19665607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A collaborative study of an alternative in vitro potency assay for the Japanese encephalitis vaccine.
    Kim BC; Kim DK; Kim HJ; Hong SH; Kim Y; Lim JM; Hong J; Kim CH; Park YK; Kim J
    Virus Res; 2016 Sep; 223():190-6. PubMed ID: 27497622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme-linked immunosorbent assay using recombinant antigens for serodiagnosis of Japanese encephalitis.
    Konishi E; Mason PW; Shope RE
    J Med Virol; 1996 Jan; 48(1):76-9. PubMed ID: 8825714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.
    Beasley DW; Li L; Suderman MT; Guirakhoo F; Trent DW; Monath TP; Shope RE; Barrett AD
    Vaccine; 2004 Sep; 22(27-28):3722-6. PubMed ID: 15315852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal vaccination approach against mosquito-borne Japanese encephalitis virus.
    Harakuni T; Kohama H; Tadano M; Uechi G; Tsuji N; Matsumoto Y; Miyata T; Tsuboi T; Oku H; Arakawa T
    Jpn J Infect Dis; 2009 Jan; 62(1):37-45. PubMed ID: 19168957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and protective efficacy of the current inactivated Japanese encephalitis vaccine against different Japanese encephalitis virus strains.
    Kurane I; Takasaki T
    Vaccine; 2000 May; 18 Suppl 2():33-5. PubMed ID: 10821971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
    Li Y; Ye J; Cao S; Xiao S; Zhao Q; Liu X; Jin M; Chen H
    J Gene Med; 2009 Feb; 11(2):150-9. PubMed ID: 19040206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological equivalence between mouse brain-derived and Vero cell-derived Japanese encephalitis vaccines.
    Abe M; Shiosaki K; Hammar L; Sonoda K; Xing L; Kuzuhara S; Kino Y; Holland Cheng R
    Virus Res; 2006 Nov; 121(2):152-60. PubMed ID: 16815584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.